Literature DB >> 14765206

Radical prostatectomy for carcinoma of the prostate.

Makoto Ohori1, Michael Kattan, Peter T Scardino, Thomas M Wheeler.   

Abstract

Morphologic features of prostatic adenocarcinoma in the radical prostatectomy (RP) specimen are powerful prognostic indicators for prognosis for disease-free survival. This review discusses the methods of sampling of the RP specimen to optimize the detection of these morphologic features, balanced against the added expense of submitting the entire gland for sectioning. Gleason grade, one of the most powerful prognostic factors, is discussed briefly, including the percent pattern 4/5 cancer compared to the standard Gleason grading. Pathologic stage, as defined by the TNM system, is discussed in detail, both in terms of precise histological definition of each category, as well as the associated prognostic implications. Surgical margin status is also important prognostically across all pathologic stages categories. Perineural invasion, which has been used diagnostically in prostate cancer for several decades, has emerged as a very important prognostic indicator as well, as determined by the quantitative aspects of tumor in the perineural space. The effect of tumor volume on prognosis is discussed, as well as the newer concepts of the prognostic significance of zone of origin of the tumor and the presence or absence of intraductal carcinoma.

Entities:  

Mesh:

Year:  2004        PMID: 14765206     DOI: 10.1038/modpathol.3800056

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

1.  [Gleason grading: diagnostic criteria and clinical implications].

Authors:  H Bonkhoff
Journal:  Pathologe       Date:  2005-11       Impact factor: 1.011

2.  Recommendations for the reporting of prostate carcinoma.

Authors:  Jonathan I Epstein; John Srigley; David Grignon; Peter Humphrey; Christopher Otis
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

3.  [Prognostic factors in prostate cancer].

Authors:  H Bonkhoff
Journal:  Pathologe       Date:  2005-11       Impact factor: 1.011

4.  Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.

Authors:  Ayumu Kido; Tsutomu Tamada; Teruki Sone; Naoki Kanomata; Yoshiyuki Miyaji; Akira Yamamoto; Katsuyoshi Ito
Journal:  Radiol Med       Date:  2016-12-09       Impact factor: 3.469

5.  Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging?

Authors:  Liang Wang; Oguz Akin; Yousef Mazaheri; Nicole M Ishill; Kentaro Kuroiwa; Jingbo Zhang; Hedvig Hricak
Journal:  BJU Int       Date:  2010-11       Impact factor: 5.588

6.  Incremental value of magnetic resonance imaging in the advanced management of prostate cancer.

Authors:  Liang Wang
Journal:  World J Radiol       Date:  2009-12-31

7.  Clustering-Based Method for Developing a Genomic Copy Number Alteration Signature for Predicting the Metastatic Potential of Prostate Cancer.

Authors:  Alexander Pearlman; Christopher Campbell; Eric Brooks; Alex Genshaft; Shahin Shajahan; Michael Ittman; G Steven Bova; Jonathan Melamed; Ilona Holcomb; Robert J Schneider; Harry Ostrer
Journal:  J Probab Stat       Date:  2012

8.  Crawling wave detection of prostate cancer: preliminary in vitro results.

Authors:  Liwei An; Bradley Mills; Zaegyoo Hah; Shuo Mao; Jorge Yao; Jean Joseph; Deborah J Rubens; John Strang; Kevin J Parker
Journal:  Med Phys       Date:  2011-05       Impact factor: 4.071

Review 9.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

10.  Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen.

Authors:  Aurélien Descazeaud; Mark Rubin; Stéphanie Chemama; Stéphane Larré; Laurent Salomon; Yves Allory; Dimitri Vordos; Andras Hoznek; René Yiou; Dominique Chopin; Claude Abbou; Alexandre de la Taille
Journal:  World J Urol       Date:  2006-11-07       Impact factor: 3.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.